A Double-Blind, Controlled Phase 2 Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Traumatic Brain Injury (TBI)
Investigator(s):
Daniel C. Lu, M.D., Ph.D.;
Organization:
UCLA
NCT Number:
Disease Name:
Traumatic Brain Injury
Disease Category:
Trial Phases:
Phase 2
Trial Status:
Closed
Trial Contact:
Courtney Real, RN
(310) 267-7433
creal@mednet.ucla.edu